Search

Erica S Y Lin

Examiner (ID: 4581, Phone: (571)270-7911 , Office: P/2853 )

Most Active Art Unit
2853
Art Unit(s)
2853, 2861
Total Applications
1103
Issued Applications
882
Pending Applications
99
Abandoned Applications
155

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16541009 [patent_doc_number] => 20200407422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => A METHOD OF INTRACELLULAR DELIVERY [patent_app_type] => utility [patent_app_number] => 16/643964 [patent_app_country] => US [patent_app_date] => 2018-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643964 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/643964
A METHOD OF INTRACELLULAR DELIVERY Sep 4, 2018 Abandoned
Array ( [id] => 13774887 [patent_doc_number] => 20190000982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => METHODS, SYSTEMS AND COMPOSITIONS RELATING TO CELL CONVERSION VIA PROTEIN-INDUCED IN-VIVO CELL REPROGRAMMING [patent_app_type] => utility [patent_app_number] => 16/120829 [patent_app_country] => US [patent_app_date] => 2018-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26654 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16120829 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/120829
Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming Sep 3, 2018 Issued
Array ( [id] => 14806303 [patent_doc_number] => 20190269761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-05 [patent_title] => METHODS, COMPOSITIONS AND SCREENS FOR THERAPEUTICS FOR THE TREATMENT OF SYNOVIAL SARCOMA [patent_app_type] => utility [patent_app_number] => 16/115440 [patent_app_country] => US [patent_app_date] => 2018-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21158 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16115440 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/115440
METHODS, COMPOSITIONS AND SCREENS FOR THERAPEUTICS FOR THE TREATMENT OF SYNOVIAL SARCOMA Aug 27, 2018 Abandoned
Array ( [id] => 14581879 [patent_doc_number] => 20190218548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => Method for Producing N-acetylglucosamine by Co-utilizing Glucose and Xylose Based on CRISPRi [patent_app_type] => utility [patent_app_number] => 16/112959 [patent_app_country] => US [patent_app_date] => 2018-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3449 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16112959 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/112959
Method for producing N-acetylglucosamine by co-utilizing glucose and xylose based on CRISPRi Aug 26, 2018 Issued
Array ( [id] => 14043921 [patent_doc_number] => 20190078067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-14 [patent_title] => HALOACID DEHALOGENASE hdl4a PROTEIN VARIANT AND METHOD OF REDUCING CONCENTRATION OF FLUORINE-CONTAINING COMPOUND IN A SAMPLE USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/107635 [patent_app_country] => US [patent_app_date] => 2018-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4770 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16107635 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/107635
HALOACID DEHALOGENASE hdl4a PROTEIN VARIANT AND METHOD OF REDUCING CONCENTRATION OF FLUORINE-CONTAINING COMPOUND IN A SAMPLE USING THE SAME Aug 20, 2018 Abandoned
Array ( [id] => 13870873 [patent_doc_number] => 20190031777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-31 [patent_title] => Compositions and Methods for Detecting, Treating and Preventing Diseases and Disorders [patent_app_type] => utility [patent_app_number] => 16/106338 [patent_app_country] => US [patent_app_date] => 2018-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27706 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16106338 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/106338
Compositions and methods for detecting, treating and preventing diseases and disorders Aug 20, 2018 Issued
Array ( [id] => 15963655 [patent_doc_number] => 20200165579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-28 [patent_title] => A RECOMBINANT FLAVIN-ADENINE DINUCLEOTIDE GLUCOSE DEHYDROGENASE AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/636013 [patent_app_country] => US [patent_app_date] => 2018-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16012 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16636013 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/636013
Recombinant flavin-adenine dinucleotide glucose dehydrogenase and uses thereof Aug 1, 2018 Issued
Array ( [id] => 13774559 [patent_doc_number] => 20190000818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases [patent_app_type] => utility [patent_app_number] => 16/046247 [patent_app_country] => US [patent_app_date] => 2018-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13187 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16046247 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/046247
Method to predict response to pharmacological chaperone treatment of diseases Jul 25, 2018 Issued
Array ( [id] => 13827179 [patent_doc_number] => 20190017074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => METHODS FOR GENOMIC INTEGRATION [patent_app_type] => utility [patent_app_number] => 16/044381 [patent_app_country] => US [patent_app_date] => 2018-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39094 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16044381 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/044381
Methods for genomic integration Jul 23, 2018 Issued
Array ( [id] => 17200475 [patent_doc_number] => 20210340570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => COMPOSITIONS AND METHODS FOR INCREASING THE EFFICIENCY OF CELL CULTURES USED FOR FOOD PRODUCTION [patent_app_type] => utility [patent_app_number] => 16/630404 [patent_app_country] => US [patent_app_date] => 2018-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22884 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630404 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/630404
Compositions and methods for increasing the efficiency of cell cultures used for food production Jul 12, 2018 Issued
Array ( [id] => 15782511 [patent_doc_number] => 10624958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-21 [patent_title] => Compositions and methods for treating pathological calcification and ossification [patent_app_type] => utility [patent_app_number] => 16/033948 [patent_app_country] => US [patent_app_date] => 2018-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 28 [patent_no_of_words] => 25810 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16033948 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/033948
Compositions and methods for treating pathological calcification and ossification Jul 11, 2018 Issued
Array ( [id] => 13778079 [patent_doc_number] => 20190002578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => Targeted Protein Degradation [patent_app_type] => utility [patent_app_number] => 16/024999 [patent_app_country] => US [patent_app_date] => 2018-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16936 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16024999 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/024999
Targeted protein degradation Jul 1, 2018 Issued
Array ( [id] => 13734081 [patent_doc_number] => 20180371508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => MICROBIAL PRODUCTION OF SUCCINATE DERIVED PRODUCTS [patent_app_type] => utility [patent_app_number] => 16/015101 [patent_app_country] => US [patent_app_date] => 2018-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8361 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16015101 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/015101
Microbial production of succinate derived products Jun 20, 2018 Issued
Array ( [id] => 18733553 [patent_doc_number] => 11802276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-31 [patent_title] => Purification of polymerase complexes [patent_app_type] => utility [patent_app_number] => 15/989109 [patent_app_country] => US [patent_app_date] => 2018-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 19805 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989109 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/989109
Purification of polymerase complexes May 23, 2018 Issued
Array ( [id] => 17858554 [patent_doc_number] => 11439692 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-13 [patent_title] => Method of treating diseases associated with MYD88 pathways using CRISPR-GNDM system [patent_app_type] => utility [patent_app_number] => 16/614145 [patent_app_country] => US [patent_app_date] => 2018-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 9646 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614145 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/614145
Method of treating diseases associated with MYD88 pathways using CRISPR-GNDM system May 16, 2018 Issued
Array ( [id] => 16091127 [patent_doc_number] => 20200199550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => CELL COMPRISING A CHIMERIC ANTIGEN RECEPTOR (CAR) [patent_app_type] => utility [patent_app_number] => 16/613312 [patent_app_country] => US [patent_app_date] => 2018-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8674 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613312 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/613312
CELL COMPRISING A CHIMERIC ANTIGEN RECEPTOR (CAR) May 13, 2018 Abandoned
Array ( [id] => 14159197 [patent_doc_number] => 20190106701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-11 [patent_title] => MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING 3-HYDROXYISOBUTYRATE OR METHACRYLIC ACID RELATED THERETO [patent_app_type] => utility [patent_app_number] => 15/979313 [patent_app_country] => US [patent_app_date] => 2018-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52760 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15979313 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/979313
MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING 3-HYDROXYISOBUTYRATE OR METHACRYLIC ACID RELATED THERETO May 13, 2018 Abandoned
Array ( [id] => 18301091 [patent_doc_number] => 11622977 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-11 [patent_title] => Materials and methods for engineering cells and uses thereof in immuno-oncology [patent_app_type] => utility [patent_app_number] => 16/613057 [patent_app_country] => US [patent_app_date] => 2018-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 103 [patent_figures_cnt] => 114 [patent_no_of_words] => 87417 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613057 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/613057
Materials and methods for engineering cells and uses thereof in immuno-oncology May 10, 2018 Issued
Array ( [id] => 13400057 [patent_doc_number] => 20180251571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-06 [patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF POMPE DISEASE [patent_app_type] => utility [patent_app_number] => 15/978075 [patent_app_country] => US [patent_app_date] => 2018-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978075 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/978075
METHODS AND COMPOSITIONS FOR TREATMENT OF POMPE DISEASE May 10, 2018 Abandoned
Array ( [id] => 14501275 [patent_doc_number] => 20190194292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => Enveloped Virus Resistant to Complement Inactivation for the Treatment of Cancer [patent_app_type] => utility [patent_app_number] => 16/303729 [patent_app_country] => US [patent_app_date] => 2018-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3962 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303729 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/303729
Enveloped virus resistant to complement inactivation for the treatment of cancer May 9, 2018 Issued
Menu